Dr. Nidhi Dhariwal
Consultant - Paediatric Haemato-oncology & BMT
Nanavati Max Institute of Cancer Care, Centre for Haematology & Bone Marrow Transplant, Hemato-Oncology & Bone Marrow Transplant, Allogeneic Bone Marrow Transplantation, Allogeneic Transplant, Autologous Transplant, Centre for Child Health, Paediatric Cancer Program
Nanavati Max Super Speciality Hospital, Mumbai
Experience: 9+ Years
Share Doctor Profile
Select Hospital
About Dr. Nidhi Dhariwal
- Consultant – Paediatric Haemato-Oncology & BMT, Nanavati Max Super Speciality Hospital, Mumbai (Sept 2025 – Present)
- Assistant Professor – Paediatric Oncology, Homi Bhabha Cancer Hospital & Research Centre, New Chandigarh (Aug 2022 – Sept 2025)
- Speciality Registrar – Paediatric Oncology, Tata Memorial Hospital, Mumbai (Aug 2021 – Jul 2022)
- Senior Resident – Paediatric Oncology, Tata Memorial Hospital, Mumbai (Aug 2018 – Aug 2021)
- Senior Resident – General Paediatrics & Neonatology, Kalawati Saran Children’s Hospital, New Delhi (Nov 2016 – Dec 2017)
- Junior Resident – General Paediatrics & Neonatology, Kalawati Saran Children’s Hospital, New Delhi (Aug 2013 – Aug 2016)
- DM (Paediatric Oncology) – Tata Memorial Hospital, Mumbai (2021)
- MD (Paediatrics) – Lady Hardinge Medical College & Kalawati Saran Children’s Hospital, New Delhi (2016)
- MBBS – Maulana Azad Medical College, New Delhi (2013)
- Indian Academy of Pediatrics (IAP)
- Pediatric Hematology & Oncology Chapter (IAP)
- International Society of Paediatric Oncology (SIOP)
- Young Investigator Award, SIOP (2020)
- First Prize – Oral Paper Presentation: “Delayed Methotrexate Clearance in Children with Philadelphia Chromosome–Positive ALL Concurrently Receiving Imatinib” at PHOCON (2019)
- Paediatric solid tumours
- Haematolymphoid malignancies
- Bone marrow transplantation
- Benign haematology
- Dhariwal N., Srinivasan S., Gollamudi V.R.M., “Acute Myeloid Leukaemia in India: A Systematic Review,” Indian Journal of Medical and Paediatric Oncology.
- Dhariwal N., Moulik N.R., Smriti V., Dhamne C., et al., “Clinico-radiological profile, management and follow-up of methotrexate-induced neurotoxicity in children with acute lymphoblastic leukaemia.”
- Dhariwal N., Moulik N.R., Bhat V., Smriti V., et al., “Intracranial disease in paediatric Hodgkin lymphoma: case report and review of literature.”
- Dhariwal N., Srinivasan S., “Minimal Disseminated Disease continues to impact outcomes in childhood ALK-positive anaplastic large-cell lymphoma: what more can we offer?”
- Srinivasan S., Narayan A., Dhamne C., Chharia A., Khera P., Dhariwal N., et al., “Low-dose nivolumab plus bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma,” British Journal of Haematology.
- Cheriyalinakal Parambil B., Moulik N.R., Dhamne C., Dhariwal N., et al., “COVID-19 in children with cancer and continuation of cancer-directed therapy during infection,” Indian Journal of Pediatrics.
- Raj R., Uppuluri R., Parambil B., Dhariwal N., et al., “Outcomes of COVID-19 in children with cancer: report from the InPOG COVID-19 registry,” Pediatric Hematology Oncology Journal.
- Dhariwal N., Gollamudi V.R.M., Raj S., Cheriyalinakal Parambil K.P.B., et al., “Platelet cancer-associated thrombosis (PCAT): analysis from a tertiary cancer centre in India,” Pediatric Blood & Cancer.
Patient Testimonials
Dr. Dr. Kaustav Talapatra, Dr. Hemant B. Tongaonkar, Dr. Manish Agarwal, Dr. Sameer Tulpule, Dr. Nidhi Dhariwal, Dr Aishwarya Shukla, Dr. Devyani Mahajan, Dr. Sasmita Vadgaonkar, Dr Vivek Mundale, Dr Sridevi Murali-Nanavati , Nanavati Max Institute of Cancer Care
